Clinical Trial Update: Comparison of cVATS Segmentectomy Versus Lobectomy for Lung Adenocarcinoma in Situ and With Microinvasion [Phase 3]

View source ↗

Summary

Phase 3 trial comparing cVATS segmentectomy versus lobectomy for early-stage lung adenocarcinoma, including adenocarcinoma in situ and microinvasive disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma
• Non-small Cell Lung Cancer

Snippet

Sponsor: The First Affiliated Hospital of Guangzhou Medical University | Conditions: Non-small Cell Lung Cancer Stage I, Lung Adenocarcinoma | Phase 3 | Status: UNKNOWN